Droperidol has comparable clinical efficacy against both nausea and vomiting.

Creative Commons License

Apfel C. C. , Cakmakkaya Ö. S. , Frings G., Kranke P., Malhotra A., Stader A., ...Daha Fazla

British journal of anaesthesia, cilt.103, ss.359-63, 2009 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 103 Konu: 3
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1093/bja/aep177
  • Dergi Adı: British journal of anaesthesia
  • Sayfa Sayıları: ss.359-63


Background. Droperidol is commonly noted to be more effective at preventing postoperative nausea (PON) than vomiting (POV) and it is assumed to have a short duration of action. This may be relevant for clinical decisions, especially for designing multiple-drug antiemetic regimens.